01Dec
Covid–19 coronavirus: global merger review
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). See our overview for an indication of the different approaches being taken by authorities around the world. Please see full...
By:
Allen & Overy LLP
Related
A consensual affair between a superior and subordinate can advance to a quid pro quo harassment clai...
Read More >
On January 13, the Committee on Foreign Investment in the United States (CFIUS) published the final ...
Read More >
Bank M&A across Europe comes to a boil—the COVID-19 pandemic has hastened the confluence of conduci...
Read More >
The District of Columbia Office of Planning (OP) recently issued a status report in response to a re...
Read More >
Building in part on amendments passed last year, the New York State Legislature has passed legislati...
Read More >
Federal authorities are prepping to “reprimand Citigroup Inc. for failing to improve its risk-manag...
Read More >